These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 31109090)
1. Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism. Czumaj A; Śledziński T; Carrero JJ; Stepnowski P; Sikorska-Wisniewska M; Chmielewski M; Mika A Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109090 [TBL] [Abstract][Full Text] [Related]
2. Potential contribution of monounsaturated fatty acids to cardiovascular risk in chronic kidney disease. Mika A; Sikorska-Wiśniewska M; Małgorzewicz S; Stepnowski P; Dębska-Ślizień A; Śledziński T; Chmielewski M Pol Arch Intern Med; 2018 Dec; 128(12):755-763. PubMed ID: 30457128 [TBL] [Abstract][Full Text] [Related]
3. The C18:3n6/C22:4n6 ratio is a good lipid marker of chronic kidney disease (CKD) progression. Szczuko M; Kaczkan M; Małgorzewicz S; Rutkowski P; Dębska-Ślizień A; Stachowska E Lipids Health Dis; 2020 Apr; 19(1):77. PubMed ID: 32303226 [TBL] [Abstract][Full Text] [Related]
4. Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism. Chen H; Chen L; Liu D; Chen DQ; Vaziri ND; Yu XY; Zhang L; Su W; Bai X; Zhao YY J Proteome Res; 2017 Apr; 16(4):1566-1578. PubMed ID: 28286957 [TBL] [Abstract][Full Text] [Related]
5. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Peter A; Cegan A; Wagner S; Lehmann R; Stefan N; Königsrainer A; Königsrainer I; Häring HU; Schleicher E Clin Chem; 2009 Dec; 55(12):2113-20. PubMed ID: 19850634 [TBL] [Abstract][Full Text] [Related]
6. Increased Expression of the Leptin Gene in Adipose Tissue of Patients with Chronic Kidney Disease-The Possible Role of an Abnormal Serum Fatty Acid Profile. Korczyńska J; Czumaj A; Chmielewski M; Śledziński M; Mika A; Śledziński T Metabolites; 2020 Mar; 10(3):. PubMed ID: 32182671 [TBL] [Abstract][Full Text] [Related]
8. Analysis of Serum Fatty Acids Profile in Kidney Transplant Recipients. Mika A; Halinski LP; Sledzinski T; Malgorzewicz S; Woloszyk P; Dardzinska J; Debska-Slizien A; Chmielewski M Nutrients; 2021 Feb; 13(3):. PubMed ID: 33671115 [TBL] [Abstract][Full Text] [Related]
9. Functional lipidomics in patients on home parenteral nutrition: Effect of lipid emulsions. Pironi L; Guidetti M; Verrastro O; Iacona C; Agostini F; Pazzeschi C; Sasdelli AS; Melchiorre M; Ferreri C World J Gastroenterol; 2017 Jul; 23(25):4604-4614. PubMed ID: 28740349 [TBL] [Abstract][Full Text] [Related]
10. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
11. Thyroid dysfunction and dyslipidemia in chronic kidney disease patients. Khatiwada S; Rajendra KC; Gautam S; Lamsal M; Baral N BMC Endocr Disord; 2015 Oct; 15():65. PubMed ID: 26510920 [TBL] [Abstract][Full Text] [Related]
12. The effect of chronic kidney disease on lipid metabolism. Dincer N; Dagel T; Afsar B; Covic A; Ortiz A; Kanbay M Int Urol Nephrol; 2019 Feb; 51(2):265-277. PubMed ID: 30519980 [TBL] [Abstract][Full Text] [Related]
13. Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease. Khurana M; Silverstein DM Pediatr Nephrol; 2015 Dec; 30(12):2073-84. PubMed ID: 25801207 [TBL] [Abstract][Full Text] [Related]
14. Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice. Newberry EP; Xie Y; Kennedy SM; Graham MJ; Crooke RM; Jiang H; Chen A; Ory DS; Davidson NO Hepatology; 2017 Mar; 65(3):836-852. PubMed ID: 27862118 [TBL] [Abstract][Full Text] [Related]
15. hiPSC-derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver. Kiamehr M; Alexanova A; Viiri LE; Heiskanen L; Vihervaara T; Kauhanen D; Ekroos K; Laaksonen R; Käkelä R; Aalto-Setälä K J Cell Physiol; 2019 Apr; 234(4):3744-3761. PubMed ID: 30146765 [TBL] [Abstract][Full Text] [Related]
16. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart. Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664 [TBL] [Abstract][Full Text] [Related]
17. A mathematical model of fatty acid metabolism and VLDL assembly in human liver. Shorten PR; Upreti GC Biochim Biophys Acta; 2005 Sep; 1736(2):94-108. PubMed ID: 16137923 [TBL] [Abstract][Full Text] [Related]
18. Dedifferentiation of Primary Hepatocytes is Accompanied with Reorganization of Lipid Metabolism Indicated by Altered Molecular Lipid and miRNA Profiles. Kiamehr M; Heiskanen L; Laufer T; Düsterloh A; Kahraman M; Käkelä R; Laaksonen R; Aalto-Setälä K Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31207892 [TBL] [Abstract][Full Text] [Related]
19. Effects of dietary fat saturation on fatty acid composition and gene transcription in different tissues of Iberian pigs. Benítez R; Núñez Y; Fernández A; Isabel B; Fernández AI; Rodríguez C; Barragán C; Martín-Palomino P; López-Bote C; Silió L; Óvilo C Meat Sci; 2015 Apr; 102():59-68. PubMed ID: 25549539 [TBL] [Abstract][Full Text] [Related]
20. Ethanol extracts of chickpeas alter the total lipid content and expression levels of genes related to fatty acid metabolism in mouse 3T3-L1 adipocytes. Shinohara S; Gu Y; Yang Y; Furuta Y; Tanaka M; Yue X; Wang W; Kitano M; Kimura H Int J Mol Med; 2016 Aug; 38(2):574-84. PubMed ID: 27353085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]